spry

Silverback Therapeutics Rings the Closing Bell in Celebration of its IPO

Date & Time
Location

ABOUT THIS EVENT

Silverback Therapeutics (Nasdaq: SBTX), a Seattle-based, clinical-stage biopharmaceutical company focused on developing systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases, rings the Nasdaq Closing Bell remotely from across the country.

Laura Shawver, Ph.D., CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.

Nasdaq watch

See what's playing at Nasdaq

WATCH NOW ->